Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis
Promoting remyelination, a major goal of an effective treatment for demyelinating diseases, has the potential to protect vulnerable axons, increase conduction velocity, and improve neurologic deficits. Strategies to promote remyelination have focused on transplanting oligodendrocytes (OLs) or recrui...
Salvato in:
| Pubblicato in: | Proc Natl Acad Sci U S A |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
National Academy of Sciences
2000
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC18751/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10841576/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.97.12.6820 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
